Do you have a Certificate of Analysis for the Direct Meds injectable Tirzepatide?

Do you have a Certificate of Analysis for the Direct Meds injectable Tirzepatide?

Certificates of Analysis (CoAs) for Tirzepatide

Each batch (or “lot”) of compounded tirzepatide prepared by the compounding pharmacy includes its own Certificate of Analysis (CoA). A CoA provides information about the testing performed on that specific lot.
Because pharmacies receive new lots regularly, it is not possible to know in advance which lot will be used for your prescription.

Direct Meds Injectable Tirzepatide COA
Notes
Compounded versions of tirzepatide are not FDA-approved. The FDA has not evaluated compounded tirzepatide for safety, effectiveness, or quality. Compounded medications may differ in formulation, strength, or supporting evidence from FDA-approved products.
Alert
This article is for general informational purposes only and does not provide medical advice, diagnosis or treatment for any specific person.